Managing Infections in Patients With Hematological Malignancies
In Managing Infections in Patients with Hematological Malignancies , the authors and editor draw on their extensive expertise while providing a roadmap for hematologists to efficiently manage the complex infections within their patients .
Review bacterial, viral, nosocomial, and intravascular infection risks and treatment options in patients with blood-related malignancies .
Managing Infectious Risk in Patients With Hematologic Malignancies
Infections are common in patients with hematologic malignancies and can lead to significant morbidity and mortality. Risk for infection is directly linked to the neutropenia induced by intensive chemotherapeutic regimens. Additional risk factors include the use of indwelling devices, Ommaya reservoirs, urinary catheters, and disruption of mucosal barriers because of radiation- or chemotherapy ...
Managing infections in patients with hematological malignancies presents several challenges, including shifting epidemiology, limited availability of rapid and reliable diagnostic methods, the effectiveness of prophylaxis, appropriate selection of empirical antibiotic therapy, drug interactions, and antibiotic resistance.
Prevention of Infection in Patients with Hematologic Malignancies
A key component of managing patients with hematologic malignancies lies in prophylaxis to prevent infections (including the use of infection control measures, antimicrobial prophylaxis, and preemptive therapy).
This book presents up-to-date knowledge on the prevention, diagnosis, and treatment of diverse infections in patients with hematologic malignancies . It devotes detailed attention to the preventive roles of vaccination and anti-infective prophylaxis and the risk stratification.
Interventions to reduce infections in patients with hematological ...
Acquired hypogammaglobulinemia is common in people with B-cell malignancies , such as chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), and multiple myeloma (MM). These conditions are associated with a multifactorial immune deficiency attributable to the underlying disease, its treatment, or both. Strategies to reduce infections are important for quality of life and mortality and ...
Abstract The clinical approach to patients with hematologic malignancies and infection requires definition of several patient factors (immunologic competence [or defect], residential environment, and the syndrome), infection factors (its type, location, progress, and pathogen), and treatment factors (medical or surgical or both). Management of patients with hematologic malignancies and ...
Critical Care Medicine
Provides a detailed update on the management of infections in patients with hematologic malignancies . Explains the preventative roles of vaccination and anti-infective prophylaxis. Describes the diagnosis and treatment of bacterial, fungal, viral, and parasitic infections .
Risk factors for infection in patients with haematological malignancies , including recipients of autologous and allogeneic haemopoietic stem-cell transplants, can be classified as endogenous (host-related factors) or exogenous (treatment-related factors) such as myeloablative therapy, total-body irradiation, high-dose steroids for severe or uncontrolled graft-versus-host disease, and ...